393 related articles for article (PubMed ID: 32708193)
1. Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy.
Yang C; Merlin D
Nanomaterials (Basel); 2020 Jul; 10(7):. PubMed ID: 32708193
[TBL] [Abstract][Full Text] [Related]
2. Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer.
Zhao Z; Li D; Wu Z; Wang Q; Ma Z; Zhang C
Front Pharmacol; 2020; 11():616101. PubMed ID: 33391000
[TBL] [Abstract][Full Text] [Related]
3. Lipid-based Nanoparticles for the Targeted Delivery of Anticancer Drugs: A Review.
Khodaverdi H; Zeini MS; Moghaddam MM; Vazifedust S; Akbariqomi M; Tebyaniyan H
Curr Drug Deliv; 2022; 19(10):1012-1033. PubMed ID: 35078396
[TBL] [Abstract][Full Text] [Related]
4. Nanoplatforms: The future of oral cancer treatment.
Senevirathna K; Jayawickrama SM; Jayasinghe YA; Prabani KIP; Akshala K; Pradeep RGGR; Damayanthi HDWT; Hettiarachchi K; Dorji T; Lucero-Prisno DE; Rajapakse RMG; Kanmodi KK; Jayasinghe RD
Health Sci Rep; 2023 Aug; 6(8):e1471. PubMed ID: 37547360
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma.
Wu K; Yu B; Li D; Tian Y; Liu Y; Jiang J
Front Oncol; 2022; 12():805978. PubMed ID: 35242707
[TBL] [Abstract][Full Text] [Related]
6. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
Wang K; Shen R; Meng T; Hu F; Yuan H
Molecules; 2022 May; 27(9):. PubMed ID: 35566331
[TBL] [Abstract][Full Text] [Related]
7. Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer.
Gupta U; Saren BN; Khaparkhuntikar K; Madan J; Singh PK
J Control Release; 2022 Aug; 348():1089-1115. PubMed ID: 35640765
[TBL] [Abstract][Full Text] [Related]
8. Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy.
Li Y; Yang J; Sun X
Front Chem; 2021; 9():650587. PubMed ID: 33968899
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in nanomedicine preparative methods and their therapeutic potential for colorectal cancer: a critical review.
Jain A; Bhattacharya S
Front Oncol; 2023; 13():1211603. PubMed ID: 37427139
[TBL] [Abstract][Full Text] [Related]
10. Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer.
Padya BS; Pandey A; Pisay M; Koteshwara KB; Chandrashekhar Hariharapura R; Bhat KU; Biswas S; Mutalik S
Eur J Pharmacol; 2021 Jan; 890():173633. PubMed ID: 33049302
[TBL] [Abstract][Full Text] [Related]
11. Targeted nanoparticles for colorectal cancer.
Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
[TBL] [Abstract][Full Text] [Related]
12. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine, an emerging therapeutic strategy for oral cancer therapy.
Marcazzan S; Varoni EM; Blanco E; Lodi G; Ferrari M
Oral Oncol; 2018 Jan; 76():1-7. PubMed ID: 29290280
[TBL] [Abstract][Full Text] [Related]
14. Functional nanoplatforms for enhancement of chemotherapeutic index.
Yang J; Lee E; Ku M; Huh YM; Cheong JH
Anticancer Agents Med Chem; 2013 Feb; 13(2):212-21. PubMed ID: 22934694
[TBL] [Abstract][Full Text] [Related]
15. Insight to drug delivery aspects for colorectal cancer.
Gulbake A; Jain A; Jain A; Jain A; Jain SK
World J Gastroenterol; 2016 Jan; 22(2):582-99. PubMed ID: 26811609
[TBL] [Abstract][Full Text] [Related]
16. Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects.
Hegde MM; Sandbhor P; J A; Gota V; Goda JS
Front Oncol; 2023; 13():1168454. PubMed ID: 37483515
[TBL] [Abstract][Full Text] [Related]
17. Single-Walled Carbon Nanohorns as Promising Nanotube-Derived Delivery Systems to Treat Cancer.
Moreno-Lanceta A; Medrano-Bosch M; Melgar-Lesmes P
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32906852
[TBL] [Abstract][Full Text] [Related]
18. Antibody-Loaded Nanoplatforms for Colorectal Cancer Diagnosis and Treatment: An Update.
Djermane R; Nieto C; Vega MA; Del Valle EMM
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242756
[TBL] [Abstract][Full Text] [Related]
19. Colorectal Cancer Management by Herbal Drug-Based Nanocarriers: An Overview.
Kulwal V; Baxi K; Sawarkar SP; Bhatt LK
Crit Rev Ther Drug Carrier Syst; 2020; 37(1):65-104. PubMed ID: 32450014
[TBL] [Abstract][Full Text] [Related]
20. New Advances in Nanotechnology-Based Diagnosis and Therapeutics for Breast Cancer: An Assessment of Active-Targeting Inorganic Nanoplatforms.
Falagan-Lotsch P; Grzincic EM; Murphy CJ
Bioconjug Chem; 2017 Jan; 28(1):135-152. PubMed ID: 27973767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
